CD8A and neoplasm: Tumor-infiltrating CD8+T cells, which exert an effector function in the TME, are associated with favorable clinical outcomes in patients receiving immunotherapy, whereas accumulation of immunosuppressive cells, such as MDSCs and Tregs, which are major mediators of immune tolerance, correlates with poor prognosis (26–28).